fda glp-1 warning letters september 2025 news Compounded Semaglutide & Tirzepatide 2025: Safe Use Guide FDA takes aim at telehealth

"GLP-1R Agonist Exendin-4 Protects Against Hemorrhagic Transformation Induced by rtPA After Ischemic Stroke via the Wnt/-Catenin Signaling Pathway"

KristensenSLRrthRJhundPSDochertyKFSattarNPreissDet alCardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

In 2010, it was alleged that Novo Nordisk breached the Association of the British Pharmaceutical Industry (ABPI) code by failing to provide information about the drugs side effects and promoting the medication before it received market authorization

Its not lack of knowledge (or protein, or strength training, or nervous system regulation)